MSB synergies/threats with Cynata, page-16

To clarify.

My use of the words "in theory" relates to the actual broader goal of the business itself. That you can, from a small donor base, build a business that markets a variety of theraputic products. That is, as yet, simply not known, as it has not occured. It's never been open to "theroetical question", that CYP's technology could do "theoretically", what they desired it to do - otherwise they would not have bought into it - independent clinical proof was required, by the regulators, to take the technology forward in to human trials.